enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sofosbuvir/velpatasvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir/velpatasvir

   In the European Union it was approved in July 2016, for the treatment of chronic hepatitis C virus infection in adults. [7] The safety and efficacy of sofosbuvir/velpatasvir for a 12-week treatment was evaluated in three Phase III clinical trials of 1,558 subjects without cirrhosis or with compensated cirrhosis (mild cirrhosis). [13]

3. Ledipasvir - Wikipedia

   en.wikipedia.org/wiki/Ledipasvir

   Ledipasvir is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. [1] After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. [2] [3] The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication ...

4. Hepatitis C - Wikipedia

   en.wikipedia.org/wiki/Hepatitis_C

   The response to treatment is measured by sustained viral response (SVR), defined as the absence of detectable RNA of the hepatitis C virus in blood serum for at least 24 weeks after discontinuing treatment, [112] and rapid virological response (RVR), defined as undetectable levels achieved within four weeks of treatment. Successful treatment ...

5. Here's What Hepatitis C Actually Is—and How You Get It - AOL

   www.aol.com/lifestyle/heres-hepatitis-c-actually...

   In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.

6. What People Who Inject Drugs Should Know about Hepatitis C ...

   www.aol.com/lifestyle/people-inject-drugs-know...

   You take one pill with or without food once a day for 12 weeks. ... Hepatitis C treatment guidelines also vary based on whether you have cirrhosis (scarring of the liver) and how severe it is. ...

7. Ledipasvir/sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Ledipasvir/sofosbuvir

   More severe reactions are connected with allergic reactions to the medications and cardiovascular problems. Harvoni side effects are considered relatively mild compared to older interferon-based treatment. [citation needed] Ledipasvir/sofosbuvir could cause hepatitis B re-activation in people co-infected with hepatitis B and C viruses.